Related Experiment Videos
[Second primary cancer in hematological malignancy experience in VGH-Taipei]
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|November 1, 1989
Summary
Patients with hematological malignancies developed secondary cancers, including lung, liver, skin, and cervical cancers, either concurrently or later. Cancer treatments like chemotherapy and radiotherapy may be associated with these secondary primary cancers.
Area of Science:
- Oncology
- Hematology
Background:
- Hematological malignancies pose significant health challenges.
- Understanding the risk of secondary primary cancers in these patients is crucial for long-term management.
Observation:
- A review of seven patients with hematological malignancy and a second primary cancer was conducted.
- These secondary cancers occurred either concurrently or subsequently to the initial hematological diagnosis.
Findings:
- Four patients had non-Hodgkin's lymphoma; three developed lung or liver cancer after chemotherapy/radiotherapy.
- One non-Hodgkin's lymphoma patient developed liposarcoma concurrently.
- Three patients had chronic lymphocytic leukemia (CLL); two had concurrent skin cancer, and one developed cervical cancer post-treatment.
Implications:
- This highlights the importance of vigilant surveillance for secondary malignancies in hematological cancer survivors.
- Therapeutic interventions for hematological cancers may influence the risk of developing other cancers.
- Further research is needed to elucidate the mechanisms and optimize screening strategies.